Dupont Capital Management’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-418
Closed -$103K 1596
2022
Q3
$103K Sell
418
-104
-20% -$28.1K 0.01% 1025
2022
Q2
$129K Buy
522
+136
+35% +$36.7K 0.01% 1132
2022
Q1
$128K Buy
386
+71
+23% +$21.9K 0.01% 1213
2021
Q4
$113K Sell
315
-169
-35% -$57.1K ﹤0.01% 1272
2021
Q3
$158K Buy
+484
New +$164K 0.01% 1287
2021
Q2
Sell
-1,147
Closed -$366K 1957
2021
Q1
$366K Buy
+1,147
New +$367K 0.01% 1076
2020
Q4
Sell
-1,865
Closed -$517K 1443
2020
Q3
$517K Sell
1,865
-295
-14% -$85K 0.01% 742
2020
Q2
$522K Buy
+2,160
New +$434K 0.01% 758
2019
Q2
Sell
-1,164
Closed -$332K 1289
2019
Q1
$332K Sell
1,164
-317
-21% -$105K 0.01% 918
2018
Q4
$481K Buy
1,481
+954
+181% +$331K 0.01% 747
2018
Q3
$237K Sell
527
-3,888
-88% -$1.53M 0.01% 852
2018
Q2
$1.81M Buy
4,415
+3,862
+698% +$1.4M 0.04% 399
2018
Q1
$161K Buy
+553
New +$140K ﹤0.01% 835
2017
Q4
Sell
-27,700
Closed -$4.67M 1008
2017
Q3
$4.67M Buy
27,700
+21,082
+319% +$3.19M 0.11% 192
2017
Q2
$948K Buy
6,618
+2,412
+57% +$324K 0.02% 538
2017
Q1
$527K Hold
4,206
0.01% 682
2016
Q4
$474K Sell
4,206
-843
-17% -$97.7K 0.01% 699
2016
Q3
$649K Sell
5,049
-4,056
-45% -$486K 0.01% 536
2016
Q2
$995K Sell
9,105
-836
-8% -$83.2K 0.02% 450
2016
Q1
$943K Buy
9,941
+1,283
+15% +$108K 0.02% 458
2015
Q4
$782K Buy
8,658
+2,751
+47% +$233K 0.02% 513
2015
Q3
$548K Hold
5,907
0.01% 524
2015
Q2
$388K Buy
+5,907
New +$392K 0.01% 535

Other funds holding ABMD

Dupont Capital Management's ABMD Position: Q4 2022 in Review

Dupont Capital Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 418 shares — an estimated $103K sold.

Dupont Capital Management first reported a position in ABMD in Q2 2015 and held it in 23 quarters. The position peaked at $4.67M in Q3 2017. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Dupont Capital Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Dupont Capital Management sold 418 Abiomed Inc shares in Q4 2022, an estimated $103K.
  • Dupont Capital Management first reported a position in Abiomed Inc in Q2 2015 and held it in 23 quarters.
  • Dupont Capital Management's Abiomed Inc position peaked at $4.67M in Q3 2017.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Dupont Capital Management's 13F filing for Q4 2022, filed 26 Jan 2023.